Advertisement
U.S. markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.5300+0.0400 (+0.89%)
At close: 04:00PM EDT
4.6081 +0.08 (+1.72%)
After hours: 07:08PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.4900
Open4.5100
Bid4.5100 x 100
Ask4.5400 x 600
Day's Range4.4850 - 4.6450
52 Week Range3.8700 - 8.0500
Volume927,379
Avg. Volume1,448,029
Market Cap1.326B
Beta (5Y Monthly)0.38
PE Ratio (TTM)N/A
EPS (TTM)-0.5100
Earnings DateMay 02, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ABCL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AbCellera Biologics Inc.
    Daily – Vickers Top Buyers & Sellers for 05/30/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more